Non-Hodgkin lymphoma in children and adolescents: progress through effective collaboration, current knowledge, and challenges ahead

V Minard-Colin, L Brugières, A Reiter… - Journal of Clinical …, 2015 - ascopubs.org
Non-Hodgkin lymphoma is the fourth most common malignancy in children, has an even
higher incidence in adolescents, and is primarily represented by only a few histologic …

Acute lymphoblastic leukemia

CH Pui, WE Evans - New England Journal of Medicine, 1998 - Mass Medical Soc
Acute lymphoblastic leukemia (ALL) is diagnosed in 3000 to 4000 persons in the United
States each year; two thirds of them are children. 1, 2 The current rate of cure of nearly 80 …

Low-intensity therapy in adults with Burkitt's lymphoma

K Dunleavy, S Pittaluga, M Shovlin… - … England Journal of …, 2013 - Mass Medical Soc
Background Burkitt's lymphoma is an aggressive B-cell lymphoma that occurs in children
and adults and is largely curable with the use of intensive and toxic chemotherapy. Current …

The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 …

C Patte, A Auperin, J Michon… - Blood, The Journal …, 2001 - ashpublications.org
This study was undertaken to show that a high survival rate can be obtained in B-cell (Burkitt
and large B-cell) lymphoma and L3 leukemia with multiagent chemotherapy adapted to the …

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce …

C Patte, A Auperin, M Gerrard, J Michon, R Pinkerton… - Blood, 2007 - ashpublications.org
A previous study (LMB89) of the French Society of Pediatric Oncology for childhood mature
B-cell lymphoma (B-NHL) demonstrated a 92% 3-year event-free survival (EFS) for …

The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study …

W Woessmann, K Seidemann, G Mann… - Blood, 2005 - ashpublications.org
Abstract In the Non-Hodgkin Lymphoma–Berlin-Frankfurt-Münster 95 (NHL-BFM95) study,
we tested by randomization whether for patients with B-cell neoplasms methotrexate as …

[HTML][HTML] Childhood cancer: occurrence, treatment and risk of second primary malignancies

S Zahnreich, H Schmidberger - Cancers, 2021 - mdpi.com
Simple Summary Childhood cancers are mostly of unknown etiology and represent
devastating diagnoses. The clinical benefits of steadily increasing tumor control and survival …

The impact of age and gender on biology, clinical features and treatment outcome of non‐Hodgkin lymphoma in childhood and adolescence

B Burkhardt, M Zimmermann, I Oschlies… - British journal of …, 2005 - Wiley Online Library
We analysed the impact of age and gender on biology and outcome of 2084 patients
diagnosed with non‐Hodgkin lymphoma (NHL) between October 1986 and December 2002 …

Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy

H Pels, IGH Schmidt-Wolf, A Glasmacher… - Journal of Clinical …, 2003 - ascopubs.org
Purpose: To evaluate response rate, response duration, overall survival (OS), and toxicity in
primary CNS lymphoma (PCNSL) after systemic and intraventricular chemotherapy with …

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and …

MS Cairo, M Gerrard, R Sposto, A Auperin… - Blood, 2007 - ashpublications.org
The prognosis for higher risk childhood B-cell non-Hodgkin lymphoma has improved over
the past 20 years but the optimal intensity of treatment has yet to be determined. Children 21 …